- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03049241
Neuromuscular Fatigue Aetiology Comparison Between Prepubertal Boys and Adults (LENGTH-FATIG)
Potential factors involved in neuromuscular fatigue were classified into two categories: 1) central factors involving the central nervous system and neural pathways, and 2) peripheral factors occurring within the muscle beyond the neuromuscular junction. In adults, it has been shown that peripheral factors contribute to a large part of the fatigue induced by repeated maximal contractions. However in children, central factors could account for the development of fatigue to a greater extent. Force-generating capacity and musculotendinous stiffness could be two of the discriminatory factors accounting for the differences in the neuromuscular fatigue between children and adults.
Force production capacity and musculotendinous stiffness vary as function of muscle length. Naturally, they could differ depending on the muscle groups studied. The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults. The investigators formulated the hypotheses that at short muscle length force and low musculotendinous stiffness, differences in force between children and adults would be reduced. Thus neuromuscular fatigue development and aetiology would be similar between both groups. The results of the present protocol will allow to better understanding of the aetiology of neuromuscular fatigue in children and help improving training or rehabilitation programs.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The study of neuromuscular fatigue in children is a recently topic in the field of sport sciences. Such knowledge could improve the efficiency and security of training and rehabilitation in healthy children and children with diseases like obesity.
The LENGTH-FATIG study will provide knowledge about the peripheral and central mechanisms of the neuromuscular fatigue in children and adults. Fatigue will test for different muscle groups (knee extensors and ankle plantar flexors) at different muscle lengths (short, optimal and long).
During high-intensity exercise, prepubertal children are more resistant to fatigue than adults. Contributions of the central and peripheral components to the development of neuromuscular fatigue are also different between both populations. The reduced children's fatigue coud be particularly related to a lower peripheral (i.e. muscular) fatigue. This might be attributed to the fact that prepubertal children rely more on oxidative than anaerobic metabolism than adults during fatiguing exercise. On the other hand, nervous factors could also explain differences in fatigue between children and adults. However, this topic is scarcely documented and still controversial. To our knowledge, no study has still compared the aetiology of central fatigue (supra-spinal vs. spinal) between children and adults. Only the voluntary activation level had been studied in children, conventionally used to assess central fatigue. But this factor doesn't differentiate spinal and supra-spinal contributions to neuromuscular fatigue development.
The LENGTH-FATIG research project is a physiological and observational study comparing two age groups (adults and children). Subjects will have to perform three randomized fatigue protocols at three muscle lengths (short, optimal and long) with the knee extensors and the ankle plantar flexors.
Data will be analyzed using LabChart 7.3 Pro software (ADInstrument, New South Wales, Australia) and Statistica 8.0 software (StatSoft, Inc.) and significance will be accepted at a two-sided alpha level of p<.05. The normality and homogeneity of the variables will be checked respectively from a Shapiro-Wilk test and a Barlett test.
If normality and homogeneity of the variables are verified, absolute values of variables (Force, EMG, NIRS, etc.) will be compared using three factors (age x muscle length x muscle group) analyses of variance (ANOVA) with repeated measures. If analyses reveal a significant effect of any factor or interaction of factors, post-hoc Newman-Keuls tests will be performed to determine differences between the different conditions.
If, on the contrary, normality and homogeneity of the variables are not verified, the effects of muscle length, muscle group and age will be evaluated using a Friedman test. If the tests show significant effects, comparisons of the different conditions will be performed using Mann-Whitney and Wilcoxon tests.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
-
Clermont-Ferrand, France, 63003
- CHU clermont-ferrand
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Boys aged 8 to 11 years old, Tanner stages 1 to 3
- Male aged 18 to 35 years old
- Non-smoker
- Moderate physical activity level (< 4h/week)
- Covered by a social health insurance
- Consent form signed by participants and/or legal guardians.
Exclusion Criteria:
- Competitive training
- Cardiac or pulmonary diseases
- Epileptic seizures past history
- Magnetic field contraindication (including cardiac valve, pacemaker, prosthesis material, ferro-magnetic foreign body, cochlear implant and ocular prosthesis material.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
knee extensors
|
The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults
|
|
ankle plantar
|
The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Maximal torque of knee extensors
Délai: once a week during six weeks.
|
once a week during six weeks.
|
|
ankle plantar flexors joint (in N.m) measured with a dynamometer.
Délai: once a week during six weeks.
|
once a week during six weeks.
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
Doublet torque amplitude (100Hz, in N.m) evoked using magnetic nerve stimulation at rest
Délai: once a week during six weeks.
|
once a week during six weeks.
|
|
Muscular tissue oxygenation (in μmol.L-1) measured at skin surface by Near-infrared spectroscopy.
Délai: once a week during six weeks
|
once a week during six weeks
|
|
Compound muscle action potential amplitude (i.e. M-wave ; in mV) evoked by supramaximal magnetic nerve stimulation and measured by surface Electromyography (EMG).
Délai: once a week during six weeks
|
once a week during six weeks
|
|
High frequency doublet (100Hz)/low frequency doublet (10Hz) ratio
Délai: once a week during six weeks
|
once a week during six weeks
|
|
fascicule length (mm) measured by B-mode real time ultrasound scanner.
Délai: once a week during six weeks
|
once a week during six weeks
|
|
pennation angle (degree) measured by B-mode real time ultrasound scanner.
Délai: once a week during six weeks
|
once a week during six weeks
|
|
Voluntary activation level (in %) assessed by using the twitch interpolation technique.
Délai: once a week during six weeks
|
once a week during six weeks
|
|
EMG signal Root mean square of EMG signal during isometric maximal voluntary contractions.
Délai: once a week during six weeks
|
once a week during six weeks
|
|
Hoffman reflex amplitude (i.e. H-reflex ; in mV) evoked by submaximal magnetic nerve stimulation measured by surface Electromyography (EMG).
Délai: once a week during six weeks
|
once a week during six weeks
|
|
Cerebral tissue oxygenation (in μmol.L-1) measured at skin surface by Near-infrared spectroscopy
Délai: once a week during six weeks
|
once a week during six weeks
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Martine DUCLOS, University Hospital, Clermont-Ferrand
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CHU-304
- 2016-A00827-44 (Autre identifiant: 2016-A00827-44)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .